Want to see QUCY full AI Analyst Report?
Quantum Cyber (QUCY) AI Stock Analysis
Top Page
Quantum Cyber
(NASDAQ:QUCY)
The score is held down primarily by weak financial performance—persistent losses, continued cash burn, and a deteriorating equity cushion—alongside bearish technical signals with the stock trading below key moving averages. Corporate developments are somewhat positive but are tempered by dilution risk from the new ATM program, while valuation metrics offer limited support due to a negative P/E and no dividend yield provided.
Quantum Cyber (QUCY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $19.12M
- Dividend Yield
- ―
- Average Volume (3M)
- 652.04K
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 1.70
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 13
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Diagnostics & Research
Quantum Cyber Business Overview & Revenue Model
Company Description
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national securi...
Quantum Cyber Financial Statement Overview
Summary
Despite meaningful gross margin improvement over time, the business remains dominated by persistent large operating/net losses, substantial ongoing cash burn (negative operating and free cash flow each year), and a weakening balance sheet with sharply higher debt-to-equity as equity has fallen—raising near-term financial risk.
Income Statement
18Very NegativeBalance Sheet
24NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 250.36K | 537.08K | 893.99K | 895.48K | 529.88K | 577.35K |
| Gross Profit | 200.20K | 389.79K | 574.88K | 509.66K | 182.15K | 177.62K |
| EBITDA | -13.31M | -15.22M | -19.56M | -24.87M | -25.72M | -11.28M |
| Net Income | -23.96M | -16.21M | -21.65M | -26.30M | -26.39M | -11.69M |
Balance Sheet | ||||||
| Total Assets | 23.37M | 5.33M | 13.50M | 15.41M | 20.24M | 10.04M |
| Cash, Cash Equivalents and Short-Term Investments | 13.38M | 889.09K | 6.24M | 7.07M | 17.14M | 8.73M |
| Total Debt | 168.67K | 2.57M | 3.50M | 7.42M | 3.23M | 2.58M |
| Total Liabilities | 3.00M | 4.69M | 7.50M | 12.16M | 6.14M | 3.68M |
| Stockholders Equity | 20.36M | 641.60K | 6.00M | 3.25M | 14.10M | 6.36M |
Cash Flow | ||||||
| Free Cash Flow | -14.50M | -12.03M | -17.34M | -23.84M | -15.43M | -3.24M |
| Operating Cash Flow | -14.36M | -10.98M | -17.09M | -21.94M | -14.77M | -3.22M |
| Investing Cash Flow | -319.74K | -1.03M | -198.82K | -1.90M | -658.48K | 1.20M |
| Financing Cash Flow | 26.32M | 6.76M | 16.60M | 14.23M | 23.94M | 10.61M |
Quantum Cyber Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QUCY, the sentiment is Negative. The current price of 0.84 is below the 20-day moving average (MA) of 1.09, below the 50-day MA of 1.27, and below the 200-day MA of 1.21, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 32.57 is Neutral, neither overbought nor oversold. The STOCH value of 22.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QUCY.
Quantum Cyber Risk Analysis
Quantum Cyber disclosed 40 risk factors in its most recent earnings report. Quantum Cyber reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksQuantum Cyber Peers Comparison
Overall Rating
INBS45Neutral
QUCY41Neutral
ISPC41Neutral
NDRA34Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | $5.84M | -0.19 | -170.36% | ― | 38.09% | 54.22% | |
| 41Neutral | $73.26M | -0.45 | -365.38% | ― | ― | ― | |
| 41Neutral | $2.08M | -0.02 | -524.37% | ― | -92.11% | 86.78% | |
| 34Underperform | $7.12M | -0.75 | -224.80% | ― | ― | 98.17% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| QUCY | Quantum Cyber N.V. | 0.84 | -0.62 | -42.47% | |
| NDRA | Endra Life Sciences | 4.75 | -0.42 | -8.12% | |
| INBS | Intelligent Bio Solutions Inc. | 1.76 | -7.52 | -81.03% | |
| ISPC | Ispecimen Inc | 0.82 | -29.16 | -97.25% | |
| BGLC | Bionexus Gene Lab Corporation | 0.92 | -4.56 | -83.27% |
Quantum Cyber Corporate Events
Quantum Cyber Announces Board and Leadership Transition
PositiveEffective October 12, 2026, Quantum Cyber N.V. appointed retired Major General Alberto C. Rosende to its Board of Directors to fill a vacancy, naming him to the audit, compensation and nomination committees and confirming his status as an independent...
Quantum Cyber Launches $100 Million ATM Equity Program
PositiveOn October 9, 2026, Quantum Cyber N.V. entered into a sales agreement with Titan Partners Securities LLC to launch an at-the-market equity offering of up to $100 million of its ordinary shares under an existing SEC shelf registration. The program all...
Quantum Cyber Sharpens Defense Focus with New U.S. Hub
PositiveOn September 25, 2026, Quantum Cyber announced a sharpened strategic focus built around three core pillars: its exclusively licensed quantum antenna for GPS-independent navigation and communications, one-way attack and interceptor drones, and the MAH...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026